Mirion Technologies, Inc. MIR
At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. 10-K, Item 1
- Employees
- 3,281
- Headquarters
- Atlanta, GA
- Next results
- around Feb 9, 2027
Where each dollar of revenue went, FY2025
Revenue of $925.4M through the costs to a net profit of $28.8M · income statement of the 10-K
MIR among Technology peers
Six ratios from the latest 10-K. Each corner is the share of 230 peers the company is above, not a score.
What changed
7 new risk paragraphs. 10-K filed Feb 19, 2026 against Feb 26, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 11 checks found nothing to note
-
Receivables +2.2% ($177.7M to $181.6M) vs revenue +7.5% ($860.8M to $925.4M), -5.3 pts apart
-
Cash from operations $143.3M vs net income $28.8M (FY ending Dec 31, 2025)
-
Inventory +14.6% ($133.2M to $152.6M) vs revenue +7.5% ($860.8M to $925.4M), +7.1 pts apart
8 more checks with nothing to note
-
Same auditor in both 10-Ks: DELOITTE & TOUCHE LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Contracts in Progress; Table of Content s
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
7 paragraphs in Risk Factors that were not in the 10-K filed Feb 26, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
We operate in complex markets and regulatory environments and that involves significant risk. You should carefully consider the following risk factors before making an investment decision as they may have an adverse effect on our business, results of operations and financial condition:
-
Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
Following the Paragon acquisition, our growth strategy relies in part on plans to supply our products and services to SMRs and other advanced reactors in the U.S., an emerging market that may grow more slowly than we expect. Our Nuclear and Safety growth strategy relies on market research that estimates that the market for SMRs will…
-
Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
In July 2025 and December 2025 we acquired Certrec and Paragon, respectively. These acquisitions may not meet our expectations. Their success, including anticipated benefits, will depend, in part, on our ability to successfully integrate our respective organizations without materially disrupting existing business and strategic…
-
Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
The use of Artificial Intelligence (AI) and machine learning in our business and operations may result in legal liability, regulatory action, increased compliance obligations, competitive or reputational harm, ethical or other concerns and adversely affect our business, financial condition and results of operations. We leverage…
New risk paragraphs, against peers
Latest 10-K of each, Technology companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $717.8M | $800.9M | $860.8M | $925.4M |
| Net income | −$276.9M | −$96.9M | −$36.1M | $28.8M |
| Operating cash flow | $39.4M | $95.2M | $99.1M | $143.3M |
| Free cash flow | $5.2M | $58.1M | $50.3M | $106.9M |
Revenue, FY2019 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$925.4M ▲ 7.5% in FY2025$28.8M in FY2025$106.9M ▲ 112.5% in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
Planned saleOct 28, 2026Loic Eloy, (President Nuclear & Safety) adopted a 10b5-1 trading plan reported in the 10-Q, up to 91,165 shares
-
10-QOct 28, 2026Quarterly report (10-Q) period ended Sep 30, 2026
-
8-KOct 27, 2026Quarterly results 8-K item 2.02
About the company
Mirion Technologies, Inc., Atlanta, GA · from the 10-K filed Feb 19, 2026
At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. As a global leader in the field of radiation safety and innovation, we bring together unrivaled expertise with an unmatched range of reliably precise technologies.
- Headquarters
- Atlanta, GA
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Oct 27, 2026
Employees, at the top of the page: "As of December 31, 2025, we employed 3,281 full-time and part-time employees" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 19, 2026 (open at SEC), compared with the 10-K filed Feb 26, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MIR/export.csv") into a cell.